4//SEC Filing
Coley Pharmaceutical Group, Inc. 4
Accession 0001181431-05-047443
CIK 0001319197operating
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 1:16 PM ET
Size
18.8 KB
Accession
0001181431-05-047443
Insider Transaction Report
Form 4
Karobath Manfred E
Director
Transactions
- Conversion
Series F Convertible Preferred Stock
2005-08-15−183,756→ 0 totalExercise: $0.25From: 2005-08-15Exp: 2005-08-15→ Common Stock (46,379 underlying) - Conversion
Series E Convertible Preferred Stock
2005-08-15−17,537→ 0 totalExercise: $0.51From: 2005-08-15Exp: 2005-08-15→ Common Stock (8,983 underlying) - Conversion
Common Stock
2005-08-15−65,502→ 135,783 total - Conversion
Common Stock
2005-08-15+46,379→ 135,783 total - Conversion
Series G Convertible Preferred Stock
2005-08-15−300,000→ 0 totalExercise: $0.22From: 2005-08-15Exp: 2005-08-15→ Common Stock (65,502 underlying) - Conversion
Common Stock
2005-08-15+8,983→ 135,783 total
Footnotes (3)
- [F1]The shares of Series E Convertible Preferred Stock converted automatically to Common Stock upon the completion of the Issuer's initial public offering on August 15, 2005.
- [F2]The shares of Series F Convertible Preferred Stock converted automatically to Common Stock upon the completion of the Issuer's initial public offering on August 15, 2005.
- [F3]The shares of Series G Convertible Preferred Stock converted automatically to Common Stock upon the completion of the Issuer's initial public offering on August 15, 2005.
Issuer
Coley Pharmaceutical Group, Inc.
CIK 0001319197
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001319197
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 1:16 PM ET
- Size
- 18.8 KB